[Myasthenia gravis and steroid therapy].
In the past 20 years, we experienced 242 myasthenic patients in our hospital. Fifty five cases were administered high doses of adrenocorticosteroid hormone for a long time. Among them, we analysed 39 cases with complete clinical records from admission to the present. We analysed 5 additional cases in whom responses to the therapy somewhat unique in that four cases have not shown any improvement until the drug was reduced to certain dosages, and in the 5th case change of method from alternate-day to every day brought good recovery of the symptoms. As a result, adrenocorticosteroid hormone was effective for 100% of the patients in this series. However, complete remission appeared in the above mentioned 10 patients (26%), after 2-3 years' continuous administration. Prognosis was far better in those who showed shorter durations between the onset of the disease and thymectomy or thymectomy than in those of longer one. In these cases, the maximum daily doses were 60-100 mg in alternate-day administration, and the total amount of prednisolone was 9-15 g in individual cases. Through data of these cases, it is recommended that the maximum dosage is to be continued for as long as 2 to 19 weeks with average 7 weeks.
Wakata
N
N
Fourth Department of Internal Medicine, Toho University.
Nemoto
H
H
Niizuma
M
M
Araki
Y
Y
Kinoshita
M
M
D000293:Adolescent; D000328:Adult; D002648:Child; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000601:surgery; D011239:Prednisolone / Q000008:administration & dosage*; D011379:Prognosis; D013934:Thymectomy; D013945:Thymoma / Q000150:complications / Q000601:surgery; D013952:Thymus Hyperplasia / Q000188:drug therapy; D013953:Thymus Neoplasms / Q000150:complications / Q000601:surgery
D011239:Prednisolone